Ryan Steadman, in Enterprise, UT - Pharmacist

Ryan Steadman, is a Pharmacist based in Enterprise, Utah. Ryan Steadman is licensed to practice in Utah (license number 6375955) and his current practice location is 660 East Main Street, #a, Enterprise, Utah. He can be reached at his office (for appointments etc.) via phone at (435) 878-2760.

NPI number for Ryan Steadman is 1356574388 and his current mailing address is 660 East Main Street #a, Enterprise, Utah. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1356574388.

Contact Information

	Ryan Steadman,
	660 East Main Street, #a, Enterprise, UT 84725
	(435) 878-2760
	Not Available

Healthcare Provider's Profile

Full Name	Ryan Steadman
Gender	Male
Speciality	Pharmacist
Location	660 East Main Street, Enterprise, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1356574388
Provider Enumeration Date: 08/25/2009
Last Update Date: 08/25/2009

Medical Identifiers

Medical identifiers for Ryan Steadman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1356574388	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	6375955 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ryan Steadman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ryan Steadman, 660 East Main Street #a, Enterprise, UT 84725 Ph: () -	Ryan Steadman, 660 East Main Street, #a, Enterprise, UT 84725 Ph: (435) 878-2760

News Archive

First Edition: September 19, 2013

Today's headlines include reports about future health spending projections from Centers for Medicare and Medicaid Services' Actuaries as well as the latest on the upcoming House vote on a stopgap funding measure that would also defund the health law.

SSRIs may minimize risk of Sudden Unexpected Death in Epilepsy

A groundbreaking study published in Elsevier's Epilepsy & Behavior provides evidence in mouse model that drugs known as Selective Serotonin Reuptake Inhibitors (SSRIs; one category of antidepressants) may reduce the risk of Sudden Unexpected Death in Epilepsy (SUDEP).

Poor oral health linked to severe mental health issues

UK study results show that individuals with severe mental illness who live in the community and receive community-based psychiatric care have poorer oral health than the national adult population.

Analysis of lens in the eye can predict patients with type 2 diabetes and prediabetes

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Barcelona, Spain (16-20 September) shows that specialist analysis of the lens in the eye can predict patients with type 2 diabetes and impaired glucose tolerance (IGT) (also known as prediabetes, a condition that often leads to full blown of type 2 diabetes).

Ryan Steadman, - Pharmacist in Enterprise, UT